US 10493066
Fumarate analogs and uses thereof
granted A61KA61K31/41A61K31/4439
Quick answer
US patent 10493066 (Fumarate analogs and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/41, A61K31/4439, A61P, A61P17/06